Anthropic's Lower IPO Valuation Signals Tougher AI Funding, Reinforcing CoreWeave's Financing Test

What happened

Anthropic is reportedly seeking $80–100 billion at a $1.5 trillion valuation, down from earlier talk of approximately $2 trillion, according to 24/7 Wall Street. The article positions CoreWeave as facing a financing test because its heavy debt load and lease obligations make it sensitive to shifts in AI capital availability. CoreWeave's own situation includes $35.6 billion of debt and $16.3 billion of lease liabilities, with recent loan pricing above 9%, reflecting credit market wariness. The news does not change CoreWeave's operational fundamentals—revenue is still mostly committed and near-term capacity is sold out—but it adds another indicator that the broader AI funding environment is becoming more selective. This aligns with the existing market narrative that has shifted from demand validation to financing durability for CoreWeave.

Implication

The lower Anthropic valuation suggests AI startups may have less capital for compute spending, which could soften future demand for CoreWeave's capacity. It also signals that equity and credit markets are applying more scrutiny to AI infrastructure, potentially raising CoreWeave's borrowing costs even further. CoreWeave's dependence on debt and leases makes it vulnerable to tighter credit conditions, which could force slower capex or equity dilution. However, because 98% of revenue comes from committed contracts and near-term capacity is effectively sold out, near-term revenue is relatively insulated. The key risk to monitor remains whether Q3 revenue meets guidance and whether liquidity stays above $15 billion; the Anthropic news is a cautionary indicator, not a thesis breaker on its own.

Thesis delta

The Anthropic IPO pricing marginally increases the probability that AI customer funding constraints will reduce future contract growth for CoreWeave. This lowers our bull scenario probability from 25% to 20% and raises the bear scenario from 30% to 35%, while the base case remains at 45%. The overall thesis and WAIT rating are unchanged, but we will now weigh customer funding announcements more heavily in our monitoring.